154 related articles for article (PubMed ID: 36281404)
21. RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.
Cheng C; Song D; Wu Y; Liu B
Front Mol Biosci; 2020; 7():218. PubMed ID: 33062641
[TBL] [Abstract][Full Text] [Related]
22. PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration.
Wang S; Wang H; Zhu S; Wang Z
Front Oncol; 2022; 12():1058506. PubMed ID: 36505799
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
25. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
26. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Sun X; Xin S; Jin L; Zhang Y; Ye L
Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
[TBL] [Abstract][Full Text] [Related]
28. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer.
Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH
Front Genet; 2021; 12():637887. PubMed ID: 33815471
[TBL] [Abstract][Full Text] [Related]
29. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
30. KNSTRN Is a Prognostic Biomarker That Is Correlated with Immune Infiltration in Breast Cancer and Promotes Cell Cycle and Proliferation.
Zhang W; Xiao Y; Zhou Q; Zhu X; Zhang Y; Xiang Q; Wu S; Song X; Zhao J; Yuan R; Xiao B; Li L
Biochem Genet; 2024 Jan; ():. PubMed ID: 38198023
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
32. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
Wang YL; Li Y; Ma YG; Wu WY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
[TBL] [Abstract][Full Text] [Related]
33. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
34. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer.
Wang B; Wang Z; Zhang T; Yang G
Exp Ther Med; 2019 Nov; 18(5):3759-3766. PubMed ID: 31616507
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of the diagnostic and prognostic value associated with the
Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T
Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318
[TBL] [Abstract][Full Text] [Related]
37. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
38. Role of PRMT5 in bladder cancer: a comprehensive study.
Ma Y; Zhong Y; Huang W
Transl Cancer Res; 2019 Apr; 8(2):491-498. PubMed ID: 35116781
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
Cheng A; Guo X; Dai X; Wang Z
FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
[TBL] [Abstract][Full Text] [Related]
40. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Huo Q; Li Z; Cheng L; Yang F; Xie N
Front Oncol; 2020; 10():621. PubMed ID: 32528869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
